Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis
TCTR20230408002Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec in diabetic ketoacidosis (DKA), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Mar 2023; status: completed.
02
Drugs
insulin degludec
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on TCTR20230408002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230408002.